The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The p53 tumour-suppressor protein controls the expression of a gene encoding the p21 cyclin-dependent protein kinase (CDK) regulator. Levels of p21 protein are increased in senescent cells and p21 overexpression blocks the growth of tumour cells. In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (PCNA). p21 controls CDK activity, thereby affecting cell-cycle control, whereas PCNA functions in both DNA replication and repair. Here we use simian virus 40 DNA replication in vitro to show than p21 directly inhibits PCNA-dependent DNA replication in the absence of a cyclin/CDK. Furthermore, p21 blocks the ability of PCNA to activate DNA polymerase delta, the principal replicative DNA polymerase. This regulation results from a direct interaction between p21 and PCNA. Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 was reported to block replicative DNA synthesis in vitro as well, doing so when reaching a 100:1 ratio [42,43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
In the citing paper
“suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA polymerases from PCNA [43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationProliferating cell nuclear antigen is required for DNA excision repair
Shivji, M. K. K., Kenny, M. K., & Wood, R. D. (1992) · Cell · doi:10.1016/0092-8674(92)90416-a · Cited by 798
Cited by
Items 601–700 of 1,000
Cyclin A: Function and expression during cell proliferation
Desdouets, C., Sobczak‐Thépot, J., Murphy, M., & Bréchot, C. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_9 · Cited by 58
DNA damage checkpoints: Implications for cancer therapy
O'Connor, P. M., & Fan, S. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_16 · Cited by 62
Sugano, T., Nitta, M., Ohmori, H., & Yamaizumi, M. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03072.x · Cited by 58
Simboeck, E., Sawicka, A., Zupkovitz, G., Senese, S., Winter, S., Dequiedt, F., Ogris, E., Di Croce, L., Chiocca, S., & Seiser, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.184481 · Cited by 57
miR‐191 suppresses angiogenesis by activation of NF‐kB signaling
Gu, Y. J., Ampofo, E., Menger, M. D., & Laschke, M. W. (2017) · The FASEB Journal · doi:10.1096/fj.201601263r · Cited by 58
Human Papillomavirus Infections: Epidemiology, Pathogenesis, and Therapy
Severson, J., Evans, T. Y., Lee, P. J., Chan, T., Arany, I., & Tyring, S. K. (2001) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540100500110 · Cited by 65
Goukassian, D. A., Eller, M. S., Yaar, M., & Gilchrest, B. A. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00468.x · Cited by 57
Li, D., Pakala, S. B., Reddy, S. D. N., Ohshiro, K., Peng, S., Lian, Y., Fu, S. W., & Kumar, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079095 · Cited by 61
The PCNA-associated factor KIAA0101/p15 binds the potential tumor suppressor product p33ING1b
Simpson, F., LAMMERTSVANBUEREN, K., Butterfield, N. C., Bennetts, J. S., Bowles, J., Adolphe, C., Simms, L. A., Young, J. P., Walsh, M. P., & Leggett, B. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.09.020 · Cited by 57
Doynova, M., Markworth, J. F., Cameron‐Smith, D., Vickers, M. H., & O'Sullivan, J. M. (2017) · Skeletal Muscle · doi:10.1186/s13395-017-0122-1 · Cited by 57
Sinicrope, F. A., Roddey, G., Lemoine, M., Ruan, S., Stephens, L. C., Frazier, M. L., Shen, Y., & Zhang, W. (1998) · PubMed · Cited by 56
p12 DOC1 , a growth suppressor, associates with DNA polymerase α/primase
Matsuo, K., Shintani, S., Tsuji, T., Nagata, E., Lerman, M. I., McBride, J., Nakahara, Y., Ohyama, H., Todd, R., & Wong, D. T. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1318 · Cited by 56
Chromosome changes caused by alterations of p53 expression
Agapova, L. S., Ilyinskaya, G. V., Turovets, N. A., Ivanov, A. V., Chumakov, P. M., & Kopnin, B. P. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(96)00062-0 · Cited by 60
Bossenmeyer‐Pourié, C., Lièvre, V., Grojean, S., Koziel, V., Pillot, T., & Daval, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00324-x · Cited by 65
p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes
Engel, F. B., Hauck, L., Boehm, M., Nabel, E. G., Dietz, R., & von Harsdorf, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.555-565.2003 · Cited by 62
Barboule, N., Mazars, P., Baldin, V., Vidal, S., Jozan, S., Martel, P., & Valette, A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630502 · Cited by 59
Zhang, S., Zhao, H. L., Darżynkiewicz, Z., Zhou, P., Zhang, Z., Lee, E. Y. C., & Lee, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490466 · Cited by 63
Masih, P. J., Kunnev, D., & Melendy, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm943 · Cited by 56
Jasinski, S., Perennes, C., Bergounioux, C., & Glab, N. (2002) · PLANT PHYSIOLOGY · doi:10.1104/pp.008573 · Cited by 57
Heinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961115)68:4<428::aid-ijc5>3.0.co;2-2 · Cited by 70
Functional Analysis of a p21 Mutant (Arg94→ Trp) Identified in a Human Breast Carcinoma
Balbín, M., Hannon, G. J., Pendás, A. M., Ferrando, A. A., Vizoso, F., Fueyo, A., & López-Otín, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15782 · Cited by 55
Self-citationInhibitors of cyclin-dependent kinase and cancer
Biggs, J. R., & Kraft, A. S. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00198902 · Cited by 60
p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus.
Puisieux, A., Ji, J., Guillot, C., Legros, Y., Soussi, T., Isselbacher, K. J., & Öztürk, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1342 · Cited by 57
Zaffaroni, N., Silvestrini, R., Orlandi, L., Bearzatto, A., Gornati, D., & Villa, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.230 · Cited by 55
Cell Cycle Checkpoint Control Mechanisms That Can Be Disrupted in Cancer
Dash, B. C., & El‐Deiry, W. S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:099 · Cited by 65
Naderi, J., Lopez, C., & Pandey, S. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.08.006 · Cited by 62
Nakakido, M., Deng, Z., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2015) · Oncotarget · doi:10.18632/oncotarget.5143 · Cited by 51
Yang, L., Lei, Q., Li, L., Yang, J., Dong, Z., & Cui, H. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0778-y · Cited by 59
Bleomycin-Mediated Pulmonary Toxicity: Evidence for a p53-Mediated Response
Mishra, A., Doyle, N. A., & Martin, W. J. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.5.3851 · Cited by 60
Cell cycle control of DNA replication
Fotedar, R., & Fotedar, A. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_6 · Cited by 59
Role for Cyclin A-dependent Kinase in DNA Replication in Human S Phase Cell Extracts
Fotedar, A., Cannella, D., FITZGERALD, P. J., Rousselle, T., Gupta, S., Dorée, M., & Fotedar, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31627 · Cited by 57
Regulation of p53-Mediated Apoptosis and Cell Cycle Arrest by Steel Factor
Abrahamson, J., Lee, J. M., & Bernstein, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6953 · Cited by 64
The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA
Gu, L., Lingeman, R. G., Yakushijin, F., Sun, E., Cui, Q., Chao, J., Hu, W., Li, H., Hickey, R. J., Stark, J. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0592 · Cited by 59
The role of apoptosis in pulmonary fibrosis.
Kuwano, K., Hagimoto, N., & Nakanishi, Y. (2004) · PubMed · doi:10.14670/hh-19.867 · Cited by 63
Giri, B., Gomes, A., Debnath, A., Saha, A., Biswas, A. K., Dasgupta, S. C., & Gomes, A. (2006) · Toxicon · doi:10.1016/j.toxicon.2006.06.011 · Cited by 53
Clabough, E. B. D., & Zeitlin, S. O. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi477 · Cited by 52
Anwar, S., Fratantonio, D., Ferrari, D., Saija, A., Cimino, F., & Speciale, A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5397 · Cited by 53
Cell cycle regulation: Repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_8.x · Cited by 59
Noya, F., Chien, W.-M., Broker, T. R., & Chow, L. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6121-6134.2001 · Cited by 43
Involvement of DNA-dependent Protein Kinase in UV-induced Replication Arrest
Park, J.-S., Park, S.-J., Peng, X., Wang, M., Yu, M.-A., & Lee, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32520 · Cited by 61
Wang, Z., Su, Z.-Z., Fisher, P. B., Wang, S., VanTuyle, G., & Grant, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4191 · Cited by 53
Biochemical and molecular mechanisms regulating apoptosis
Saini, K. S., & Walker, N. I. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006891430596 · Cited by 62
Lee, B. H., & Mathews, M. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4481 · Cited by 59
Haapajärvi, T., Kivinen, L., Heiskanen, A., Bordes, C. D., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4403 · Cited by 66
da Costa, R. P. R., Serrão, P. M., Monteiro, S., Pessa, P., Silva, J. R., & Ferreira-Dias, G. M. (2007) · Reproduction Fertility and Development · doi:10.1071/rd06159 · Cited by 52
Yu, Y., Cai, J., Tu, B., Wu, L., Zhao, Y., Liu, X., Li, L., McNutt, M. A., Feng, J., He, Q., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015289 · Cited by 58
Karagiannakos, A., Adamaki, M., Tsintarakis, A., Vojtěšek, B., Fåhræus, R., Zoumpourlis, V. C., & Karakostis, K. (2022) · Cancers · doi:10.3390/cancers14030664 · Cited by 62
Tanaka, M., Lee, K., Martínez‐Augustin, O., He, Y., Sanderson, I. R., & Walker, W. A. (1996) · Journal of Nutrition · doi:10.1093/jn/126.2.424 · Cited by 52
Ruan, S., Okcu, M. F., Pong, R. C., Andreeff, M., Levin, V. A., Hsieh, J. T., & Zhang, W. (1999) · PubMed · Cited by 51
p53 Protects renal inner medullary cells from hypertonic stress by restricting DNA replication
Dmitrieva, N. I., Michea, L., & Burg, M. B. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.3.f522 · Cited by 53
Tahara, H., Smith, A. P., Gaz, R. D., & Arnold, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3663 · Cited by 54
Miller, S. D., Moses, K., Jayaraman, L., & Prives, C. L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2194 · Cited by 59
Baekelandt, M. M. O., Holm, R., Tropé, C. G., Nesland, J. M., & Kristensen, G. B. (1999) · PubMed · Cited by 52
Cytokeratins and cell differentiation in the pancreas
Bouwens, L. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199803)184:3<234::aid-path28>3.0.co;2-d · Cited by 122
Frimerman, A., Welch, P. J., Jin, X., Eigler, N. L., Yei, S., Forrester, J. S., Honda, H., Makkar, R., Barber, J. R., & Litvack, F. (1999) · Circulation · doi:10.1161/01.cir.99.5.697 · Cited by 57
Sequential replication-coupled destruction at G1/S ensures genome stability
Coleman, K. E., Grant, G. D., Haggerty, R. A., Brantley, K., Shibata, E., Workman, B. D., Dutta, A., Varma, D., Purvis, J. E., & Cook, J. G. (2015) · Genes & Development · doi:10.1101/gad.263731.115 · Cited by 51
p15PAF Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression
Chang, C.-N., Feng, M.-J., Chen, Y., Yuan, R., & Jeng, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061196 · Cited by 51
Shimamoto, K., Hayashi, H. D., Taniai, E., Morita, R., Imaoka, M., Ishii, Y., Suzuki, K., Shibutani, M., & Mitsumori, K. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.775 · Cited by 51
Said, R. S., Nada, A. S., & El‐Demerdash, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050928 · Cited by 51
Cell cycle alterations and lung cancer.
Vincenzi, B., Schiavon, G., Silletta, M., Santini, D., Perrone, G., Marino, M. D., Angeletti, S., Baldi, A., & Tonini, G. (2006) · PubMed · doi:10.14670/hh-21.423 · Cited by 53
Ets-1 Protects Vascular Smooth Muscle Cells from Undergoing Apoptosis by Activating p21WAF1/Cip1
Zhang, C., Kavurma, M. M., Lai, A. K. W., & Khachigian, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304328200 · Cited by 51
Kato, M. V., Sato, H., Nagayoshi, M., & Ikawa, Y. (1997) · Blood · doi:10.1182/blood.v90.4.1373 · Cited by 52
Stivala, L. A., Riva, F., Cazzalini, O., Savio, M., & Prosperi, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204132 · Cited by 57
Momand, J., & Zambetti, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970301)64:3<343::aid-jcb1>3.0.co;2-v · Cited by 168
Wang, Z., Tuyle, G. V., Conrad, D. H., Fisher, P. B., Dent, P., & Grant, S. (1999) · PubMed · Cited by 51
Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1
Cariou, S., Catzavelos, C., & Slingerland, J. M. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006154900130 · Cited by 64
UV-triggered p21 degradation facilitates damaged-DNA replication and preserves genomic stability
Mansilla, S. F., Soria, G., Vallerga, M. B., Habif, M., Martinez-Lopez, W., Prives, C., & Gottifredi, V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt475 · Cited by 50
Whether to target single or multiple CDKs for therapy? That is the question
Węsierska‐Gądek, J., Maurer‐Granofszky, M., Zulehner, N., & Komina, O. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22426 · Cited by 53
Zhan, J., Easton, J. B., Huang, S., Mishra, A., Xiao, L., Lacy, E. R., Kriwacki, R. W., & Houghton, P. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00086-06 · Cited by 53
Sun, Y., Hildesheim, A., Li, H., Li, Y., Chen, J. Y., Cheng, Y. J., Hayes, R. B., Rothman, N., Bi, W., & Cao, Y. (1995) · PubMed · Cited by 58
Naderi, S., Wang, J. Y. J., Chen, T.-T., Gützkow, K. B., & Blomhoff, H. K. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-06-0501 · Cited by 55
The Growth-Regulatory Role of p21 (WAF1/CIP1)
Gartel, A. L., & Tyner, A. L. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_4 · Cited by 57
Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression
Xu, H., Wang, Z., Jin, S., Hao, H.-J., Zheng, L., Zhou, B., Zhang, W., Lv, H., & Yuan, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.105 · Cited by 53
Sun, Z., Zhou, C., Liu, F., Zhang, W., Chen, J., Pan, Y., Ma, L., Liu, Q., Du, Y., Yang, J., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.7434 · Cited by 49
Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways
Meng, L., Ji, R., Dong, X., Xu, X., Xin, Y., & Jiang, X. M. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4787 · Cited by 59
Calcium-mediated activation of PI3K and p53 leads to apoptosis in thyroid carcinoma cells
詩子, 井., Chen, G. G., Vlantis, A. C., Tse, G. M., Shum, C. K. Y., & van Hasselt, C. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7107-x · Cited by 49
Southern, S. A., & Herrington, C. S. (2000) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2000.010004263.x · Cited by 54
A role for p53 in terminal epithelial cell differentiation
Saifudeen, Z. R., Dipp, S., & El-Dahr, S. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13972 · Cited by 54
Shi, Y.-Z., Hui, A.-M., Takayama, T., Li, X., Cui, X., & Makuuchi, M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1310 · Cited by 50
p21 WAF-1 reorganizes the nucleus in tumor suppression
Linares‐Cruz, G., Bruzzoni‐Giovanelli, H., Alvaro, V., Roperch, J.-P., Tuynder, M., Schoëvaërt, D., Nemani, M., Prieur, S., Lethrosne, F., Piouffre, L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1131 · Cited by 49
Expression of p21(waf1/cip1) Protein in Transitional Cell Bladder Tumours and Its Prognostic Value
Lipponen, P., Aaltomaa, S. H., Eskelinen, M., Ala‐Opas, M., & Kosma, V. (1998) · European Urology · doi:10.1159/000019721 · Cited by 49
Bai, H.-Z., Morishita, R., Kida, I., Yamakawa, T., Zhang, W., Aoki, M., Matsushita, H., Noda, A., Nagai, R., Kaneda, Y., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300640 · Cited by 48
Zhang, X., Min, K., Wimalasena, J., & Baek, S. J. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1276-1 · Cited by 48
A proposal: Evolution of PCNA's role as a marker of newly replicated DNA
Georgescu, R. E., Langston, L. D., & O’Donnell, M. E. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.01.015 · Cited by 51
Targeted p21 WAF1/CIP1 Activation by RNAa Inhibits Hepatocellular Carcinoma Cells
Kosaka, M., Kang, M. R., Yang, G., & Li, L.-C. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0354 · Cited by 48
p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
Manu, K. A., Cao, P. H. A., Chai, T. F., Casey, P. J., & Wang, M. (2019) · Cancers · doi:10.3390/cancers11081112 · Cited by 53
Liu, J.-Y., Fu, W.-Q., Zheng, X., Wan, L., Ren, L., Wang, J., Yang, C., & Du, G. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0404-8 · Cited by 48
Wu, L. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-137 · Cited by 48
Halaschek-Wiener, J., Wacheck, V., Schlagbauer‐Wadl, H., Wolff, K. S., Kloog, Y., & Jansen, B. (2000) · Molecular Medicine · doi:10.1007/bf03402049 · Cited by 48
Chieffi, P., Franco, R., Fulgione, D., & Staibano, S. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7500 · Cited by 48
Wu, M., Bellas, R. E., Shen, J., & Sonenshein, G. E. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1671 · Cited by 53
Inactivation of MyoD-mediated expression of p21 in tumor cell lines.
Otten, A. D., Firpo, E. J., Gerber, A. N., Brody, L. L., Roberts, J. M., & Tapscott, S. J. (1997) · PubMed · Cited by 56
Further Characterization of Human DNA Polymerase δ Interacting Protein 38
Xie, B., Li, H., Wang, Q., Xie, S., Rahmeh, A., Dai, W., & Lee, M. Y. W. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414597200 · Cited by 48
Boussiotis, V. A., Chen, Z.-M., Zeller, J. C., Murphy, W. J., Berezovskaya, A., Narula, S. K., Roncarolo, M. G., & Blazar, B. R. (2001) · Blood · doi:10.1182/blood.v97.2.565 · Cited by 54
Proliferative lifespan checkpoints: Cell-type specificity and influence on tumour biology
Wynford‐Thomas, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00064-6 · Cited by 53
Inhaled Asbestos Fibers Induce p53 Expression in the Rat Lung
Mishra, A., Liu, J. Y., Brody, A. R., & Morris, G. F. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.4.9115760 · Cited by 47
Ioachim, E. E. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01105.x · Cited by 49
Atawia, R. T., Tadros, M. G., Khalifa, A. E., Mosli, H. A. M., & Abdel‐Naim, A. B. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.03.002 · Cited by 48
Xie, Y., Su, N. Y., Jin, M., Qi, H., Yang, J., Li, C., Du, X., Luo, F., Chen, B., Shen, Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds181 · Cited by 50
Trombetta, A., Togliatto, G., Rosso, A., Dentelli, P., Olgasi, C., Cotogni, P., & Brizzi, M. F. (2012) · Diabetes · doi:10.2337/db12-0646 · Cited by 53
Metadata
- Authors
- Waga, S., Hannon, G. J., Beach, D., & Stillman, B.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1994-06
- Volume
- 369
- Issue
- 6481
- Pages
- 574-578
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003282728
- Cited by
- 1,655
- References
- 31
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 21 · 2023: 22 · 2022: 25 · 2021: 17 · 2020: 25 · 2019: 31 · 2018: 23 · 2017: 25 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 23 · 2012: 49
- FWCI
- 55.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p21, cyclin-dependent kinases, PCNA, proliferating cell nuclear antigen, DNA replication, DNA polymerase delta, p53, cell cycle regulation, DNA repair, protein-protein interaction, tumor suppression
- MeSH terms
- Cell Division, Cell Line, DNA Polymerase III, DNA-Directed DNA Polymerase, DNA Replication, DNA Topoisomerases, Type I, DNA, Viral, Histidine, Humans, Nuclear Proteins, Recombinant Proteins, Simian virus 40, Cyclins, Proliferating Cell Nuclear Antigen, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.